SCHEMBL20127396

SCHEMBL20127396

c1ccc2cc(-c3ccc4c(c3)oc3c(-c5c6ccccc6c(-c6ccc7ccccc7c6)c6ccccc56)c5ccccc5cc34)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 2/20 0.40
CYP1A1 P04798 1/20 0.40
GPR84 Q9NQS5 2/20 0.39
ALOX5 P09917 2/20 0.38
ESR1 P03372 2/20 0.35
ESR2 Q92731 2/20 0.35
CYP1A2 P05177 4/20 0.35
CYP2C9 P11712 4/20 0.35
HSD17B1 P14061 3/20 0.35
HSD17B2 P37059 3/20 0.35
CYP2C19 P33261 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2B6 P20813 2/20 0.35
DYRK1A Q13627 1/20 0.35
HCRTR1 O43613 1/20 0.34
NOTUM Q6P988 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HSD17B10 Q99714 2/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127397 0.96 ESR1 (0.40) CYP1B1CYP1A1GPR84ALOX5ESR1
SCHEMBL20127365 0.94 CYP1B1 (0.42) CYP1B1CYP1A1GPR84ALOX5ESR1
SCHEMBL22180699 0.94 HCRTR1 (0.39) CYP1B1CYP1A1GPR84ALOX5ESR1
SCHEMBL20127460 0.93 GPR84 (0.39) CYP1B1CYP1A1GPR84ALOX5ESR1
SCHEMBL10122559 0.92 GPR84 (0.40) CYP1B1CYP1A1GPR84ALOX5ESR1
SCHEMBL20127366 0.91 PRKDC (0.40) CYP1B1CYP1A1GPR84ALOX5ESR1
SCHEMBL20127398 0.90 CYP1A2 (0.40) CYP1B1CYP1A1GPR84ALOX5CYP1A2
SCHEMBL10122553 0.90 HSD17B1 (0.38) CYP1B1CYP1A1GPR84ALOX5ESR1
SCHEMBL20127367 0.90 ESR1 (0.41) CYP1B1CYP1A1GPR84ALOX5ESR1
SCHEMBL20127400 0.89 GPR84 (0.39) CYP1B1CYP1A1GPR84ALOX5ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 CYP1B1 341/4885CYP1A1 399/4885GPR84 2389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.